Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH)

Published:2020-06-02 Issue:6 Volume:29 Page:623-632
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Fiorucci Stefano¹,Biagioli Michele¹,Sepe Valentina²,Zampella Angela²,Distrutti Eleonora³

Affiliation:

1. Dipartimento Di Scienze Biomediche E Chirurgiche, Università Di Perugia, Perugia, Italy

2. Dipartimento Di Farmacia, Università Di Napoli ‘ Federico II’, Napoli, Italy

3. SC Di Gastroenterologia Ed Epatologia, Azienda Ospedaliera Di Perugia, Perugia, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2020.1763302

Reference66 articles.

1. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

2. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

3. Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy?

4. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease

5. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated serum metabolomics, 16S rRNA sequencing and bile acid profiling to reveal the potential mechanism of gentiopicroside against nonalcoholic steatohepatitis in lean mice;Journal of Ethnopharmacology;2024-11

2. Osteokines in Nonalcoholic Fatty Liver Disease;Current Obesity Reports;2024-09-03

3. Unveiling structural determinants for FXR antagonism in 1,3,4-trisubstituted-Pyrazol amide derivatives: A multi-scale in silico modelling approach;Computers in Biology and Medicine;2024-09

4. Current strategies for nonalcoholic fatty liver disease treatment (Review);International Journal of Molecular Medicine;2024-08-08

5. Computational study of novel natural agonists targeting farnesoid X receptor;Scientific Reports;2024-07-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3